MAGELLAN LONGEVITY
HomeResearchStudy library › Thresholds of handgrip strength for all-cause, cancer, and…
Study summary · Cardiovascular & vascular aging

Is the association between handgrip strength and all-cause, cancer, and cardiovascular mortality dose-dependent?

In one paragraph

Grip-Strength Dynamometer, a systematic review and meta-analysis (Ageing Res Rev 2022, PMID 36332759) — dose-response meta-analyses showed that higher handgrip strength significantly reduced all-cause mortality risk within 26-50 kg in a close-to-linear inverse fashion. The abstract for Grip-Strength Dynamometer states no limitations.

Source: Ageing Res Rev 2022, PMID 36332759 ↗ · Research map · How Magellan grades evidence · evidence confidence: medium

Ageing Res Rev · 2022 · PMID 36332759 · DOI 10.1016/j.arr.2022.101778

Plain-English summary written and published by Magellan Longevity · medical review by Gabriel Radu, DO (physiatrist, NPI 1376861765). We summarize what the paper reported — we did not run this study.

The takeaway

Lower handgrip strength is linked to increased mortality risk, with the specific dose-response varying by cause of death.

The question

Is the association between handgrip strength and all-cause, cancer, and cardiovascular mortality dose-dependent?

What they tested

The study aimed to investigate the dose-response relationship of handgrip strength with all-cause, cancer, and cardiovascular mortality.

How they did it

A systematic review and meta-analysis were conducted using data from PubMed/MEDLINE, Web of Science, and Scopus up to February 8, 2022. Prospective cohort studies of healthy adults with objective handgrip strength measures were included. A random forest model and a two-stage random-effects hierarchical meta-regression model were used to analyze the dose-response relationship for all-cause, cancer, and cardiovascular mortality.

What they found

Forty-eight studies with 3,135,473 participants (49.6% women, aged 35-85 years) were included. Random forest models indicated a significant inverse association between handgrip strength and all-cause and cause-specific mortality. Dose-response meta-analyses showed that higher handgrip strength significantly reduced all-cause mortality risk within 26-50 kg in a close-to-linear inverse fashion. Cancer mortality showed a U-shaped association with significant risk reduction between 16 and 33 kg, while cardiovascular mortality displayed a close-to-linear inverse shape with significant risk reduction ranging from 24 to 40 kg.

Handgrip Strength Ranges for Significant Mortality Risk Reduction
Values shown: Handgrip Strength (kg)
All-cause mortality38
Cancer mortality24.5
Cardiovascular mortality32

The midpoint of the handgrip strength range associated with significant risk reduction for different mortality causes.

What it means

There is strong evidence that lower handgrip strength is associated with higher all-cause, cancer, and cardiovascular mortality risk. The dose-response relationship of handgrip strength varies substantially depending on the cause of mortality.

Limitations

The abstract does not explicitly state limitations of the study.

Where the published abstract does not list limitations, we say so rather than inventing them. Read the full paper on PubMed before drawing conclusions.

“lower handgrip strength associated with higher all-cause, cancer, and cardiovascular mortality risk”— from the published abstract, Ageing Res Rev 2022

The paper at a glance

TitleThresholds of handgrip strength for all-cause, cancer, and cardiovascular mortality: a meta-analysis
JournalAgeing Res Rev
Year2022
PMID36332759 ↗
DOI10.1016/j.arr.2022.101778 ↗
TopicCardiovascular & vascular aging

Read the source: PubMed record (authors, abstract, full citation) ↗ · Publisher via doi.org ↗

Where Magellan uses this paper

This citation sits behind the evidence grade on the pages below. Grades are set from the research and are independent of affiliate commissions.

Grip-Strength Dynamometer

Across large prospective cohorts and meta-analyses, lower grip strength is consistently associated with higher all-cause and cardiovascular mortality, incident cardiovascular disease, disability, and, in some studies, cognitive decline and depression, often predicting outcomes as well as or better than systolic blood…

Hand Grip Dynamometer Pro

Across large prospective cohorts (notably the 17-country PURE study and UK Biobank) and multiple meta-analyses pooling millions of participants, lower grip strength is consistently and independently associated with higher all-cause and cardiovascular mortality, and with cognitive decline, disability, sarcopenia and…

Grip-Strength Dynamometer

A hand-grip (handgrip) dynamometer is a simple handheld device that measures the maximal isometric…

Check price on Amazon ↗

Hand Grip Dynamometer Pro

A hand-grip dynamometer measures the maximal isometric force generated by the muscles of the hand and…

Check price on Amazon ↗

Research describes the compound or intervention studied. It is not a claim about any specific product.

Molecules & mechanisms in this paper

Each of these is named in the paper’s own words above. Open the monograph for the full mechanism and its other citations.

Cite this page

These citations point at this summary. To cite the original paper with its full author list, use the PubMed record or doi.org.

APA
Magellan Longevity. (2026). Is the association between handgrip strength and all-cause, cancer, and cardiovascular mortality dose-dependent? [Plain-English summary of Ageing Res Rev 2022, PMID 36332759, DOI 10.1016/j.arr.2022.101778]. Magellan Longevity. https://magellanlongevity.com/study/d36332759.html
BibTeX
@misc{magellan_d36332759, title = {Is the association between handgrip strength and all-cause, cancer, and cardiovascular mortality dose-dependent?}, author = {{Magellan Longevity}}, year = {2026}, howpublished = {\url{https://magellanlongevity.com/study/d36332759.html}}, note = {Plain-English summary of PubMed PMID 36332759; DOI 10.1016/j.arr.2022.101778; Ageing Res Rev 2022. Reviewed by Gabriel Radu, DO}, urldate = {2026-08-11} }
Permalink
https://magellanlongevity.com/study/d36332759.html

Related studies in the Magellan library

All 67 Magellan summaries on cardiovascular & vascular aging →

How this summary was made. Every section above restates what the published abstract of PMID 36332759 reports — the question, the design, the numbers, the authors’ own conclusion and their stated limitations. We do not add claims the paper did not make, and we keep negative and no-effect findings in. Magellan’s evidence grades are set from research like this and never from affiliate commissions.

Prefer the interactive version? Open this summary in the Magellan app → · Browse all 314 study summaries →

Educational information, not medical advice. This is a plain-English summary of published research; it is not a treatment recommendation and nothing here is intended to diagnose, treat, cure, or prevent any disease. Individual studies can be wrong, and a single paper rarely settles a question. Talk to your physician before acting on any research, especially if you are pregnant, nursing, or taking medication.